Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print Cancer scientists create 'human' leukemia process to map how disease begins, progresses

Cancer scientists create 'human' leukemia process to map how disease begins, progresses

April 27, 2007

Cancer researchers led by Dr. John Dick at Ontario Cancer Institute (OCI) have developed a method to convert normal human blood cells into "human" leukemia stem cells. The converted cells, when transplanted into special mice that permit the growth of human cells, can replicate the entire disease process from the very moment it begins. The findings are published in the journal Science.

Dr. Dick, Senior Scientist at OCI, the research arm of Princess Margaret Hospital, and a Professor in the Department of Molecular Genetics, University of Toronto, said: "Most human leukemia research involves studying a patient's diseased cells or a cell line grown from those cells. However, since cancer takes many months or years to develop, just studying the cells at the end of the process does not let you know what the series of changes were that caused the cells to become leukemic, and when they happened.




"With the method we developed, we have duplicated the natural process every step of the way. The method we developed opens the pathway generally to understanding the process of how cancer begins."

The scientific team of Frederic Barabe, James Kennedy and Kristin Hope introduced a specific leukemia gene into normal human stem cells and injected the genetically altered cells into mice that lacked immune systems. The result? 100% of the mice developed fatal leukemia that displayed the same characteristics and patterns of human disease.

For the past 20 years, said Dr. Dick, leukemia research has focused mainly on human cells where the disease already exists or by studying leukemia created in mouse cells. This study flipped it around to focus on asking which are the normal cells within which the disease arises and then how it evolves and progresses, all within the context of human cells.

"So what we are building is a new approach and way of studying how leukemia arises in the first place. We found that with the leukemia gene we were using, the disease only arose from immature stem and progenitor cells. The leukemic stem cells that were created seemed to change as the human leukemia was grown for longer times in a series of transplanted mice. Our findings of how these leukemic stem cells functioned could explain several features of the leukemia in children and adults that also contain the same leukemia gene, MLL-ENL."

In 1994, Dr. Dick identified the first cancer stem cell in leukemia, following on the original discovery in 1962 of the blood stem cell by two other renowned OCI scientists, Drs. Ernest McCulloch and James Till -- a discovery that formed the basis of all current stem cell research. Dr. Dick, who holds the Canada Research Chair in Stem Cell Biology and is also Senior Scientist at the Toronto General Research Institute and at the McEwen Centre for Regenerative Medicine, University Health Network, recently published other findings showing that colon cancer arises from stem cells specific to the tumour.

Princess Margaret Hospital



Related Leukemia News Articles Leukemia News and Current Leukemia Events RSS Leukemia News and Current Leukemia Events RSS
VCU Massey Cancer Center Spearheads Novel Clinical Study for Lymphoma Patients
The Virginia Commonwealth University Massey Cancer Center recently opened a National Cancer Institute (NCI)-sponsored, phase II clinical study for certain sub-types of non-Hodgkin's lymphoma.

New insights into the regulation of PTEN tumor suppression function
The PTEN tumor suppressor gene controls numerous biological processes including cell proliferation, cell growth and death. But PTEN is frequently lost or mutated; in fact, alteration of the gene is so common among various types of human cancer that PTEN has become one of the most frequently mutated of all tumor suppressors.

Children's national co-leads nationwide study of landmark sickle cell treatment
Children's National Medical Center immunologist and blood and marrow transplant physician Naynesh Kamani, MD, will serve as the study co-chair for a new national clinical trial of unrelated donor marrow and umbilical cord blood transplants for severe sickle cell disease.

Newly discovered molecular switch helps decide cell type in early embryo development
Researchers have discovered a central molecular switch in fruit fly embryos that opens new avenues for studying the causes of birth defects and cancer in humans. Writing about their study in the Aug. 12 Developmental Cell, scientists at Cincinnati Children's Hospital Medical Center determined the switch to be a main tuning mechanism for instructing cells whether to form sensory nerves or blood cells in different parts of the body.

McGill researchers overcome chemotherapy resistance in the lab
Researchers from McGill University's Faculty of Medicine have discovered a compound that reduces resistance to chemotherapy agents used to treat cancer. Their results were published in the June issue of The Journal of Clinical Investigation (JCI).

Crucial Factors in Lymphoma Development and Survival Discovered
Researchers at National Jewish Medical and Research Center have discovered an important factor in the development of B-cell lymphomas, one of the fastest growing forms of cancer.

Leukemia drug could save lives of stroke patients
The drug tPA is the most effective treatment currently available for stroke patients, but its safety is limited to use within the first three hours following the onset of symptoms.

Stroke study reveals key target for improving treatment and suggests that Gleevec may help
For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.

Math could help cure leukemia
When kids complain that math homework won't help them in real life, a new answer might be that math could help cure cancer.

Combining math and medicine to treat leukemia
Researchers have produced a mathematical model that may lead to the development of an optimally-timed vaccine for chronic myelogenous leukemia (CML).
More Leukemia News Articles


My Sister's Keeper: A Novel
by Jodi Picoult

New York Times bestselling author Jodi Picoult is widely acclaimed for her keen insights into the hearts and minds of real people. Now she tells the emotionally riveting story of a family torn apart by conflicting needs and a passionate love that triumphs over human weakness.Anna is not sick, but she might as well be. By age thirteen, she has undergone countless surgeries, transfusions, and shots...



Drums, Girls, And Dangerous Pie
by Jordan Sonnenblick

Thirteen-year-old Steven has a totally normal life: he plays drums in the All-Star Jazz band, has a crush on the hottest girl in the school, and is constantly annoyed by his five-year-old brother, Jeffrey. But when Jeffrey is diagnosed with leukemia, Steven's world is turned upside down. He is forced to deal with his brother's illness and his parents' attempts to keep the family in one piece....



Sadako and the Thousand Paper Cranes (PMC) (Puffin Modern Classics)
by Eleanor Coerr

Born in Hiroshima in 1943, Sadako was the star of her school’s running team, until the dizzy spells started and she was forced to face the hardest race of her life—the race against...



It's Only Temporary: The Good News and the Bad News of Being Alive
by Evan Handler

A provocative, funny, and whip- smart memoir of how one man learned to find joy in his own life after years of hand-to-hand combat with death. Actor and author Evan Handler’s new book, It’s Only Temporary, is both a deeply personal memoir and a series of meditations on life, love, faith, gratitude, and mortality. In closely examining his own triumphs, mistakes, and less-than-ideal relationships...



Gideon's Gift (The Red Gloves Collection #1)
by Karen Kingsbury

One long-ago Christmas, Big Earl Gibson lost the two things most precious to him-his wife and daughter. Angry and heartbroken, he abandoned his belief in God and is now living on the street. Gideon is a seven-year-old leukemia patient determined to reach out to this lonely and hurting man. And Earl is just as determined to rebuff her. It is only through a miracle that Earl finally comes to...



The Rainmaker
by John Grisham

Michael Beck (The Golden Seal, Xanadu), who seems to be making a career out of reading books on audio (A Time to Kill, The Runaway Jury), has returned with John Grisham's The Rainmaker, bringing the backwoods of Tennessee's legal world to life. His sultry, southern drawl animates the world of Rudy Baylor, an out-of-luck, budding lawyer who has more things going against him than bedraggled, ...



Childhood Leukemia: A Guide for Families, Friends and Caregivers (3rd Edition)
by Nancy Keene

This most complete parent guide covers not only detailed and precise medical information about leukemia and the various treatment options, but also day-to-day practical advice on how to cope with procedures, hospitalization, family and friends, school, social and financial issues, communication, feelings, and, if therapy is not successful, the difficult issues of death and bereavement. Woven...



The Breuss Cancer Cure: Advice for the Prevention and Natural Treatment of Cancer, Leukemia and Other Seemingly Incurable Diseases
by Rudolf Breuss



Sadako
by Eleanor Coerr



100 Questions & Answers About Lymphoma
by Peter Holman, Jodi Garrett, William D. Jansen

This book deals with lymphoma from a doctor's and a caregiver's...

© 2008 BrightSurf.com